Group
Genomics
5 themes63 tickers
10D rank#42of 129 groups
Dive into Genomics, where we explore who's at the cutting edge of gene editing, sequencing hardware, and who interprets all that genetic data. These companies are all about unlocking life's code for biotech and creating healthcare breakthroughs.
Genomics '25: Gene Editing & Genetic Meds+32.47%20.0%
Genomics '25: Genomics Tools & Automation+48.78%20.0%
Genomics '25: Molecular Diagnostics & Clinical Genomics+64.91%20.0%
Genomics '25: Sequencing Hardware+30.43%20.0%
Genomics '25: Synthentic Biology & Biofoundries+33.36%20.0%
As of Jul 10, 2026, 7:14 AM ET
Themes in this group
Build 20260710T074722
| Genomics '25: Gene Editing & Genetic Meds | 15 | $1.53B | $22.96B | +0.59% | -3.30% | +5.33% | +4.64% | +34.47% | +40.38% | +11.68% | -24.42% | +19.32% | +117.14% | -0.92% | +28.75% |
| Genomics '25: Genomics Tools & Automation | 14 | $31.20B | $436.75B | +0.39% | +6.17% | +3.83% | +1.90% | +35.69% | +46.78% | +31.34% | -22.48% | +24.11% | +62.57% | -3.98% | +12.55% |
| Genomics '25: Molecular Diagnostics & Clinical Genomics | 18 | $5.53B | $99.48B | +0.60% | +4.80% | +3.32% | +1.16% | +13.89% | +66.95% | +196.27% | +27.54% | +30.01% | +95.02% | -4.25% | +47.16% |
| Genomics '25: Sequencing Hardware | 7 | $77.79B | $544.55B | +1.52% | +3.37% | +0.65% | +1.24% | +10.54% | +29.26% | +73.53% | -64.09% | +8.01% | +50.94% | -0.68% | -1.01% |
| Genomics '25: Synthentic Biology & Biofoundries | 12 | $1.94B | $23.27B | +0.92% | +3.22% | -2.55% | -1.20% | +49.65% | +35.01% | +30.83% | -50.92% | +62.65% | +67.96% | -1.08% | +31.81% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary